Cargando…

Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer

BACKGROUND: Thioredoxin-1 (Trx-1) is a small redox protein, which plays an important role in many biological processes. Although increased expression of Trx-1 in various solid tumors has been reported, the prognostic significance and function of Trx-1 in human gastric cancer (GC) are still unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Wenjing, Xie, Zhongdong, Lu, Fengying, Fang, Daoquan, Tang, Tianbin, Bi, Ruichun, Chen, Lingli, Jiang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398115/
https://www.ncbi.nlm.nih.gov/pubmed/30911354
http://dx.doi.org/10.1155/2019/9291683
_version_ 1783399531209031680
author Shang, Wenjing
Xie, Zhongdong
Lu, Fengying
Fang, Daoquan
Tang, Tianbin
Bi, Ruichun
Chen, Lingli
Jiang, Lei
author_facet Shang, Wenjing
Xie, Zhongdong
Lu, Fengying
Fang, Daoquan
Tang, Tianbin
Bi, Ruichun
Chen, Lingli
Jiang, Lei
author_sort Shang, Wenjing
collection PubMed
description BACKGROUND: Thioredoxin-1 (Trx-1) is a small redox protein, which plays an important role in many biological processes. Although increased expression of Trx-1 in various solid tumors has been reported, the prognostic significance and function of Trx-1 in human gastric cancer (GC) are still unclear. Here, we investigated the clinical and prognostic significance of Trx-1 expression and the function and mechanism of Trx-1 in human GC. METHODS: We analyzed Trx-1 mRNA expression from the GEO database and Trx-1 protein expression in 144 GC tissues using immunohistochemistry. Effects of Trx-1 on GC cell were assessed in vitro and in vivo through Trx-1 knockdown or overexpression. The antitumor effects of the Trx-1 inhibitor, PX-12, on GC cells were investigated. PTEN and p-AKT expressions were evaluated by Western blotting. RESULTS: Increased Trx-1 expression was found in GC tissues and associated with poor prognosis and aggressive clinicopathological characteristics in patients with GC. High Trx-1 expression predicted poor prognosis, and its expression was an independent prognostic factor for overall survival of GC patients. Knockdown of Trx-1 expression inhibited GC cell growth, migration, and invasion in vitro and tumor growth and lung metastasis in vivo. Conversely, overexpression of Trx-1 promoted GC cell growth, migration, and invasion. We also found that PX-12 inhibited GC cell growth, migration, and invasion. Overexpression of Trx-1 caused a decrease in PTEN and increase in p-AKT levels whereas silencing Trx-1 caused an increase in PTEN and decrease in p-AKT levels in GC cells. Inhibition of AKT signaling pathway by MK2206 also inhibited GC cell growth, migration, and invasion. CONCLUSION: Our results indicate that Trx-1 may be a promising prognostic indicator and therapeutic target for GC patients.
format Online
Article
Text
id pubmed-6398115
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63981152019-03-25 Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer Shang, Wenjing Xie, Zhongdong Lu, Fengying Fang, Daoquan Tang, Tianbin Bi, Ruichun Chen, Lingli Jiang, Lei Oxid Med Cell Longev Research Article BACKGROUND: Thioredoxin-1 (Trx-1) is a small redox protein, which plays an important role in many biological processes. Although increased expression of Trx-1 in various solid tumors has been reported, the prognostic significance and function of Trx-1 in human gastric cancer (GC) are still unclear. Here, we investigated the clinical and prognostic significance of Trx-1 expression and the function and mechanism of Trx-1 in human GC. METHODS: We analyzed Trx-1 mRNA expression from the GEO database and Trx-1 protein expression in 144 GC tissues using immunohistochemistry. Effects of Trx-1 on GC cell were assessed in vitro and in vivo through Trx-1 knockdown or overexpression. The antitumor effects of the Trx-1 inhibitor, PX-12, on GC cells were investigated. PTEN and p-AKT expressions were evaluated by Western blotting. RESULTS: Increased Trx-1 expression was found in GC tissues and associated with poor prognosis and aggressive clinicopathological characteristics in patients with GC. High Trx-1 expression predicted poor prognosis, and its expression was an independent prognostic factor for overall survival of GC patients. Knockdown of Trx-1 expression inhibited GC cell growth, migration, and invasion in vitro and tumor growth and lung metastasis in vivo. Conversely, overexpression of Trx-1 promoted GC cell growth, migration, and invasion. We also found that PX-12 inhibited GC cell growth, migration, and invasion. Overexpression of Trx-1 caused a decrease in PTEN and increase in p-AKT levels whereas silencing Trx-1 caused an increase in PTEN and decrease in p-AKT levels in GC cells. Inhibition of AKT signaling pathway by MK2206 also inhibited GC cell growth, migration, and invasion. CONCLUSION: Our results indicate that Trx-1 may be a promising prognostic indicator and therapeutic target for GC patients. Hindawi 2019-02-18 /pmc/articles/PMC6398115/ /pubmed/30911354 http://dx.doi.org/10.1155/2019/9291683 Text en Copyright © 2019 Wenjing Shang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shang, Wenjing
Xie, Zhongdong
Lu, Fengying
Fang, Daoquan
Tang, Tianbin
Bi, Ruichun
Chen, Lingli
Jiang, Lei
Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title_full Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title_fullStr Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title_full_unstemmed Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title_short Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
title_sort increased thioredoxin-1 expression promotes cancer progression and predicts poor prognosis in patients with gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398115/
https://www.ncbi.nlm.nih.gov/pubmed/30911354
http://dx.doi.org/10.1155/2019/9291683
work_keys_str_mv AT shangwenjing increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT xiezhongdong increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT lufengying increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT fangdaoquan increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT tangtianbin increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT biruichun increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT chenlingli increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer
AT jianglei increasedthioredoxin1expressionpromotescancerprogressionandpredictspoorprognosisinpatientswithgastriccancer